» Articles » PMID: 26697208

Human Coinfection with Borrelia Burgdorferi and Babesia Microti in the United States

Overview
Journal J Parasitol Res
Publisher Wiley
Specialty Parasitology
Date 2015 Dec 24
PMID 26697208
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Borrelia burgdorferi, the causative agent of Lyme disease, and Babesia microti, a causative agent of babesiosis, are increasingly implicated in the growing tick-borne disease burden in the northeastern United States. These pathogens are transmitted via the bite of an infected tick vector, Ixodes scapularis, which is capable of harboring and inoculating a host with multiple pathogens simultaneously. Clinical presentation of the diseases is heterogeneous and ranges from mild flu-like symptoms to near-fatal cardiac arrhythmias. While the reason for the variability is not known, the possibility exists that concomitant infection with both B. burgdorferi and B. microti may synergistically increase disease severity. In an effort to clarify the current state of understanding regarding coinfection with B. burgdorferi and B. microti, in this review, we discuss the geographical distribution and pathogenesis of Lyme disease and babesiosis in the United States, the immunological response of humans to B. burgdorferi or B. microti infection, the existing knowledge regarding coinfection disease pathology, and critical factors that have led to ambiguity in the literature regarding coinfection, in order to eliminate confusion in future experimental design and investigation.

Citing Articles

A customizable multiplex protein microarray for antibody testing and its application for tick-borne and other infectious diseases.

Krishnamurthy H, Jayaraman V, Krishna K, Wang T, Bei K, Changalath C Sci Rep. 2025; 15(1):2527.

PMID: 39833196 PMC: 11747503. DOI: 10.1038/s41598-024-84467-0.


Development, Optimization, and Validation of a Quantitative PCR Assay for Detection in Tick, Wildlife, and Human Samples.

Lewis J, Lloyd V, Robichaud G Pathogens. 2025; 13(12.

PMID: 39770294 PMC: 11679815. DOI: 10.3390/pathogens13121034.


Prevalence of Co-Infection with Other Tick-Borne Pathogens in Pennsylvania.

Nijjar L, Schwartz S, Koon Koon D, Marin S, Jimenez M, Williams T Microorganisms. 2024; 12(11).

PMID: 39597609 PMC: 11596951. DOI: 10.3390/microorganisms12112220.


Babesiosis: Analysis of the Evidence for Infections in the United Kingdom.

Cook M, Puri B Int J Gen Med. 2024; 17:4627-4631.

PMID: 39429956 PMC: 11488525. DOI: 10.2147/IJGM.S485759.


Beyond Human Babesiosis: Prevalence and Association of Coinfection with Mortality in the United States, 2015-2022: A Retrospective Cohort Study.

Ssentongo P, Venugopal N, Zhang Y, Chinchilli V, Ba D Open Forum Infect Dis. 2024; 11(10):ofae504.

PMID: 39381028 PMC: 11460071. DOI: 10.1093/ofid/ofae504.


References
1.
McKisic M, Barthold S . T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease. Infect Immun. 2000; 68(9):5190-7. PMC: 101777. DOI: 10.1128/IAI.68.9.5190-5197.2000. View

2.
Thompson C, Spielman A, Krause P . Coinfecting deer-associated zoonoses: Lyme disease, babesiosis, and ehrlichiosis. Clin Infect Dis. 2001; 33(5):676-85. DOI: 10.1086/322681. View

3.
Kraiczy P, Hellwage J, Skerka C, Becker H, Kirschfink M, Simon M . Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins. J Biol Chem. 2003; 279(4):2421-9. DOI: 10.1074/jbc.M308343200. View

4.
Lobo C, Cursino-Santos J, Alhassan A, Rodrigues M . Babesia: an emerging infectious threat in transfusion medicine. PLoS Pathog. 2013; 9(7):e1003387. PMC: 3708872. DOI: 10.1371/journal.ppat.1003387. View

5.
Hellwage J, Meri T, Heikkila T, Alitalo A, Panelius J, Lahdenne P . The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem. 2000; 276(11):8427-35. DOI: 10.1074/jbc.M007994200. View